NCT04947059View on ClinicalTrials.gov

Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)

PHASE3RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Bladder Cancer
Interventions
DRUG

Gemcitabine Hydrochloride combined with continuous saline irrigation

Immediate single intravesical instillation with gemcitabine combined with continuous saline irrigation in bladder cancer patients who are treated with a transurethral resection of the tumor

DRUG

Epirubicin Hydrochloride combined with continuous saline irrigation

Immediate single intravesical instillation with epirubicin combined with continuous saline irrigation in bladder cancer patients who are treated with a transurethral resection of the tumor

Trial Locations (1)

41110

RECRUITING

Urology Department, University of Thessaly, University Hospital of Larissa, Larissa

All Listed Sponsors
lead

University of Thessaly

OTHER